Mitochondrial respiratory chain proteins (MRC)

The mitochondrial respiratory chain (MRC) is a series of multi-subunit protein complexes (Complexes I-V) and electron carriers (ubiquinone and cytochrome c) located in the inner mitochondrial membrane that execute oxidative phosphorylation (StatPearls, 2023). These proteins facilitate the transfer of electrons from NADH and FADH2 to molecular oxygen, coupled with the pumping of protons to create an electrochemical gradient used by ATP synthase to generate ATP (UniProt, 2024). Beyond energy production, the MRC is a primary source of reactive oxygen species (ROS) and plays a central role in regulating cellular apoptosis and metabolic signaling (PubMed, 2022). Dysfunctions in these proteins are implicated in primary mitochondrial diseases like Leigh syndrome, as well as common conditions including neurodegenerative diseases, type 2 diabetes, and various cancers (NIH, 2023). Therapeutic targeting of the MRC includes the use of Complex I inhibitors like Metformin for metabolic control and novel inhibitors like IACS-010759 for OXPHOS-dependent malignancies (Nature Reviews Cancer, 2019). However, pharmacological intervention carries significant risks, such as lactic acidosis and systemic toxicity, due to the essential role of mitochondrial respiration in maintaining organ function (PubMed, 2021).

Other names

Electron transport chainOxidative phosphorylation systemOXPHOSMitochondrial electron transport chainRespiratory chain complexes

Inhibition of electron transfer through complexes I-IV or inhibition of ATP synthase (Complex V) to disrupt the electrochemical gradient and reduce ATP production (Nature Reviews Drug Discovery, 2020).